Previous Article | Next Article ![]()
J. Virol., Dec 1997, 9124-9133, Vol 71, No. 12
A Knappe, C Hiller, M Thurau, S Wittmann, H Hofmann, B Fleckenstein and H Fickenscher
Herpesvirus saimiri C488 transforms human T lymphocytes to stable growth in
culture. The growth-transformed human T cells harbor the viral genome in a
nonintegrated episomal form without production of virus particles. In these
cells, virus gene expression was previously found to be confined to the
transforming genes stpC and tip. In order to analyze virus gene expression
in more detail, we applied a subtractive hybridization technique and
compared stimulated virus- transformed cells with uninfected parental T
cells of the same donor. A number of known T-cell activation genes were
isolated. Viral stpC/tip cDNAs were enriched after subtraction. In
addition, the viral immediate- early, superantigen-homologous gene
ie14/vsag was represented by numerous cDNA clones that comprised the entire
spliced transcript. Whereas a weak basal expression of ie14/vsag was
detected by reverse transcription-PCR only, the phorbol ester-induced
transcripts were readily shown by Northern blotting. ie14/vsag, which
before had been classified as a major immediate-early gene of herpesvirus
saimiri, is localized within a highly conserved region with extensive
homologies to the cellular genome. Mutant viruses without the ie14/vsag
gene are replication competent and fully capable of transforming human and
marmoset T cells. Since ie14/vsag is transiently expressed after
stimulation, it may increase T-cell proliferation in an activation-
dependent and superantigen-like but apparently Vbeta-independent way.
Copyright © 1997, American Society for Microbiology
The superantigen-homologous viral immediate-early gene ie14/vsag in herpesvirus saimiri-transformed human T cells
Institut fur Klinische und Molekulare Virologie, Friedrich-Alexander- Universitat Erlangen-Nurnberg, Erlangen, Germany.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|